Skip to content
lifestyle.spaziotribu.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Kenai Therapeutics/BIOCOM
Kenai Therapeutics Appoints Mark Gergen to Board of Directors
August 20, 2026
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson’s Disease
July 7, 2026
Kenai Therapeutics Appoints Allen Waldrop to Board of Directors
March 12, 2026